Search PubMed⌕ Search

Biomedical subjects

H Zilcher

Publications and source records attributed to H Zilcher.

At least 19 recordsLinked to original sources

Ketanserin combined with a beta-blocker or diuretic in essential hypertension. A multicentre study.

The antihypertensive effect of ketanserin 40 mg b.d. in combination with a beta-adrenergic blocking agent or a diuretic was assessed in an open study in 35 patients with essential hypertension, who had not responded to treatment with beta-blockers, diuretics or their combination. The ketanserin/beta-blocker combination decreased mean sitting systolic/diastolic blood pressure (SBP/DBP) from 169/107 mmHg to 156/91 mmHg at the end of the 12-week active treatment period. The decrease in systolic blood pressure was significant only at Week 8, while the decrease in diastolic blood pressure was highly significant at all times. A significant reduction in heart rate by 10 beats.min-1 was observed with the ketanserin + beta-blocker combination. The ketanserin/diuretic combination led to a significant reduction in mean SBP/DBP from 164/106 mmHg to 146/92 mmHg after 12 weeks, with no significant change in heart rate. Body weight slightly increased in both groups. There were significantly fewer adverse reactions with the ketanserin/diuretic combination than with the ketanserin/beta-blocker combination. The results indicate a potentially useful therapeutic role for ketanserin in combination with beta-blockers or diuretics.

Adrenergic beta-Antagonists↗

[Modern aspects of cardiogenic shock].

Since the introduction of coronary care units the in-hospital mortality decreased in acute myocardial infarction (AMI), but not the mortality which persisted at about 90% in cardiogenic shock (CS). the definition of CS is based on a cardiac index of greater than 2.2 1/min/m2 and an advancing lactate acidosis with lactate values of about 4.0 mmol/1 which leads to death in most cases by the so-called secondary ventricular fibrillation. Measurements of invasive haemodynamic parameters like cardiac index etc. were superseded by clinical parameters because of methodological problems in clinical routine. Forrester deals with clinical parameters and the pulmonary wedge pressure to separate 4 haemodynamically different subsets in the acute stage of AMI. The treatment of cardiogenic shock uses the manipulation of pre- and/or afterload. Nitrates reduce an increased PCV to normal values because of dilating the capacity vessels (preload) which leads to venous pooling. The cardiac index increases up to 20%. Vasodilators (Na-nitroprusside, phentolamine, prazosin, hydralazine, captopril) also caused an increase of the cardiac index because of afterload reduction. This therapeutic strategy demands exact continuous arterial blood pressure monitoring. A perfusion pressure greater than 80 mm Hg on an average will extend the infarction area in narrowed coronary arteries. Positive inotropic drugs (dopamine, dobutamine, amrinone) increase the contractility of the injured myocardium. From the haemodynamic point of view the best results can be achieved by application of temporary intraaortic counterpulsation (IABP) by reducing afterload and increasing diastolic perfusion of the coronary arteries. Nevertheless IABP is of restricted value because of high rate of pump-dependence.

Hemodynamics↗

Value of exercise testing for prediction of physical and psychosocial rehabilitation potential 3 months after acute myocardial infarction.

In 147 patients exercise tests were performed at the beginning and after 1 year of an ambulatory rehabilitation program. Measurements of both tests and the degree of functional improvement were correlated with patients' characteristics, the results of a psychological analysis using the Freiburger Personality Inventory and a patient's questionnaire for self-assessment. Among the major determinants for functional improvement were age, location of the infarct, rate of participation and greater initial functional impairment. High degree of psychosomatic impairment accompanied low levels of exercise capacity, the patients' self-assessment showed no correlation with exercise performance.

Adult↗

[Therapy of ventricular tachyarrhythmias refractory to lidocaine with propafenone (author's transl)].

Lidocaine is most widely used for suppression of recurrent ventricular tachyarrhythmias by IV application. Advantages are good control and low incidence of signs of cardiac toxicity. Most important disadvantage is lack of possibility to continue therapy by oral administration. A serious problem is a high rate of non-responders, between 15 and 50% according to the literature. In our patients, rate of non-responders is about 25%. In these patients, other antiarrhythmic agents can be used, but therapeutic success is even more uncertain because of a higher rate of non-responders and adverse reactions in most instances. We administered Propafenone as drug of second choice in 30 patients with ventricular tachyarrhythmias refractory to Lidocaine. Initial bolus injection of 1-2 mg/kg body weight followed by drip infusion (0,2-0,5 mg/kg body weight/hr) or oral administration in those patients who responded to the initial bolus injection (83%). This regimen allowed sufficient control of the tachyarrhythmia in all patients of the responder group. Serious adverse reactions of cardiac origin were fall of blood pressure and exorbitant widening of QRS-complexes in three patients. A demonstration of a patient dying from pump failure with extremely widened QRS-complexes is given. Therefore we ask for caution regarding administration of Propafenone in patients with serious diffuse myocardial damage. Propafenone therefore seems to be well suited for therapy of ventricular tachyarrhythmias refractory to Lidocaine because of its low rate of non-responders and the possibility to continue treatment of oral administration of the drug.

Administration, Oral↗

[Calcium induced necroses of cardiac muscle causing death in acute hyperparathyroidism (author's transl)].

Typical symptoms of acute myocardial infarction led to admission of a 66-year-old female. Creatine kinase (CK) was 720 U/l on admission and together with CK-MB of 108 U/l fitted the clinical picture. The ECG showed complete left bundle branch block. The patient died a few hours later in cardiac failure. Massive hypercalcaemia of 6.2 mmol/l and hyperphosphataemia of 1.6 mmol/l suggested acute primary hyperparathyroidism already clinically which later could be verified by a parathormone level of more than 100 000 ng/l ("C-terminal assay"). At necropsy chief cell adenoma of the epithelial bodies was found, typical changes of primary hyperparathyroidism in the skeleton and kidneys, and disseminated calcifications and fresh necroses of cardiac muscle. The coronaries were normal. This is the first clinical report of fatal acute primary hyperparathyroidism due to hypercalcaemia-induced myocardial necroses.

Acute Disease↗